The latest advancements in upper gastrointestinal (GI) cancer treatment include early detection tools, immunotherapy, ...

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...

Aberrations in fibroblast growth factor receptors FGFR2/3 are major drivers of many cancers-including intrahepatic ...

For years, developing selective FGFE2/3 inhibitors has been hindered by the extreme structural similarity among FGFR family members, leading to toxicities and resistance with current therapies.

A groundbreaking trial for TYRA-300, an oral FGFR3 inhibitor, aims to transform treatment for patients with low-grade ...

Carlsbad, California Tuesday, July 1, 2025, 16:00 Hrs [IST] ...

Lung cancer can be hereditary, with mutations in the EGFR and KRAS genes potentially playing a role. Smoking, however, is by far the biggest risk factor.

A membrane transport protein called SLC13A5 has previously been linked to a severe form of epileptic encephalopathy.